Back to Results

Henry Schein Inc (HSIC)

Henry Schein, Inc. is a common stock listing on NASDAQ for a healthcare company that supplies products and services to office-based dental and medical professionals around the world. The company operates through three segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. Its distribution and services business includes a broad range of dental and medical supplies, equipment, pharmaceuticals, vaccines, diagnostic products, repair services, financial services on a non-recourse basis, continuing education, and consulting. The specialty products segment focuses on dental implant and biomaterial products, along with endodontic, orthodontic, orthopedic, and related healthcare products. The technology segment develops and distributes practice management software, e-services, and other solutions for healthcare providers. Henry Schein serves dental practices, laboratories, physician practices, ambulatory surgery centers, and other care settings. The company was founded in 1932 and is headquartered in Melville, New York.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-HSIC
$82.66
-3.5% Downside
Fair
$88.50
3.3% Upside
Fair
Good
—
—
—
0.0%
August 11, 2026
24.7x
3.0x
0.7x
9.82 B
14.329 B
24.8%
82.4%
4.6
—
112.7%
Send a message
Valuation • Fair Value

Henry Schein Inc (NASDAQ-HSIC) Fair Value by Valuation Model

Compare the primary fair value estimate for Henry Schein Inc (NASDAQ-HSIC) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$82.66

Estimated downside of 3.5% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$86.89

Discounted cash flow valuation reference.

Ben Graham Formula Value

$38.47

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$65.94

Earnings power value estimate.

Comps Fair Value

$81.21

Comparable-company valuation reference.

Analyst Price Target

$88.50

Analysts imply upside of 3.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Henry Schein Inc (NASDAQ-HSIC) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Henry Schein Inc (NASDAQ-HSIC)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

13.384 B

Current operating scale indicator.

Revenue Forecast

13.739 B

Forward revenue estimate.

EBITDA

1.048 B

Current operating profitability reference.

EBITDA Forecast

1.169 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Henry Schein Inc (NASDAQ-HSIC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Henry Schein Inc (NASDAQ-HSIC)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.50

No elevated caution signal from this screen.

Altman Z-Score

4.6

Relatively strong balance-sheet zone.

FCF / Net Income

112.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Henry Schein Inc (NASDAQ-HSIC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Henry Schein Inc (NASDAQ-HSIC)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 11, 2026

Days to Earnings

21

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Henry Schein Inc (NASDAQ-HSIC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Henry Schein Inc (NASDAQ-HSIC) Stock Forecast & Technical Outlook

Review Henry Schein Inc (NASDAQ-HSIC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Henry Schein Inc (NASDAQ-HSIC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Henry Schein Inc (NASDAQ-HSIC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Henry Schein Inc (NASDAQ-HSIC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Henry Schein Inc (NASDAQ-HSIC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Henry Schein Inc (NASDAQ-HSIC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Henry Schein Inc (NASDAQ-HSIC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Henry Schein Inc (NASDAQ-HSIC) has a Hold consensus, with 5 buy, 7 hold and 1 sell recommendations in the current data set.

Buy 5
Hold 7
Sell 1
FAQ • Fast Investor Answers

Henry Schein Inc (NASDAQ-HSIC) Stock FAQ

Quick answers about Henry Schein Inc (NASDAQ-HSIC) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$82.66
Estimated downside 3.5%
Valuation Rating
Overvalued
Estimated downside of 3.5%
Analyst Target
$88.50
Implied upside 3.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for Henry Schein Inc (NASDAQ-HSIC) is $82.66. This implies an estimated downside of 3.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 3.5% versus the current market price.

The available analyst price target for Henry Schein Inc (NASDAQ-HSIC) is $88.50. The analyst target implies estimated upside of 3.3%.

The current financial health read for Henry Schein Inc (NASDAQ-HSIC) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Henry Schein Inc (NASDAQ-HSIC) is August 11, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Henry Schein Inc (NASDAQ-HSIC) is 24.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Henry Schein Inc is 9.82 B.

The current enterprise value listed for Henry Schein Inc is 14.329 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Henry Schein Inc is NASDAQ-HSIC, and the stock is listed on NASDAQ.

Henry Schein Inc (NASDAQ-HSIC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Henry Schein Inc is 24.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Henry Schein Inc is 82.4%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on NASDAQ View more

Guardant Health Inc (GH) Guardant Health Inc (GH)
Brightspring Health Services Inc (BTSG) Brightspring Health Services Inc (BTSG)
Brightspring Health Services Inc Unit (BTSGU) Brightspring Health Services Inc Unit (BTSGU)
The Ensign Group Inc (ENSG) The Ensign Group Inc (ENSG)
Healthequity Inc (HQY) Healthequity Inc (HQY)
RadNet Inc (RDNT) RadNet Inc (RDNT)
Lifestance Health Group Inc (LFST) Lifestance Health Group Inc (LFST)
Alignment Healthcare LLC (ALHC) Alignment Healthcare LLC (ALHC)
Option Care Health Inc (OPCH) Option Care Health Inc (OPCH)
Privia Health Group Inc (PRVA) Privia Health Group Inc (PRVA)
Acadia Healthcare Company Inc (ACHC) Acadia Healthcare Company Inc (ACHC)
CorVel Corp (CRVL) CorVel Corp (CRVL)
Progyny Inc (PGNY) Progyny Inc (PGNY)
Clover Health Investments Corp (CLOV) Clover Health Investments Corp (CLOV)
Aveanna Healthcare Holdings Inc (AVAH) Aveanna Healthcare Holdings Inc (AVAH)
Surgery Partners Inc (SGRY) Surgery Partners Inc (SGRY)
Addus HomeCare Corporation (ADUS) Addus HomeCare Corporation (ADUS)
Astrana Health Inc (ASTH) Astrana Health Inc (ASTH)
NeoGenomics Inc (NEO) NeoGenomics Inc (NEO)
GeneDx Holdings Corp (WGS) GeneDx Holdings Corp (WGS)
InnovAge Holding Corp (INNV) InnovAge Holding Corp (INNV)
Adapthealth Corp (AHCO) Adapthealth Corp (AHCO)
Pennant Group Inc (PNTG) Pennant Group Inc (PNTG)
Omada Health Inc (OMDA) Omada Health Inc (OMDA)